Sarah Bianchi, Evercore ISI public policy chief strategist, joins 'Squawk Box' to discuss the short-term government funding ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $307.2, a high ...

Evercore ISI raised the firm’s price target on BridgeBio (BBIO) to $50 from $45 and keeps an Outperform rating on the shares ...

Retrenchment in industry has led to concerns about the spread of ‘pharmacy deserts’ with limited access to medicines ...

Tax-loss selling candidates such as Nike, could surprise investors with big gains in 2025, say Evercore strategists.

Cabaletta Bio Inc (CABA) stock saw a decline, ending the day at $2.36 which represents a decrease of $-0.02 or -0.84% from the prior close of $2.38. The stock opened at $2.4 and touched a low of $2.25 ...

Evercore ISI analyst Gavin Clark-Gartner maintained a Buy rating on Rocket Pharmaceuticals (RCKT – Research Report) on December 20 and set a ...

Super Micro Computer Inc. has brought on Evercore Inc. to help the company raise capital, according to people familiar with ...

Keefe Bruyette upgraded Evercore (EVR) to Outperform from Market Perform with a price target of $339, up from $269. The firm says that despite ...

Julian Emanuel, Evercore ISI senior managing director, joins 'Fast Money' to warn of a possible market pullback early next ...

Across the recent three months, 5 analysts have shared their insights on Evercore (NYSE:EVR), expressing a variety of opinions spanning from bullish to bearish. The table below offers a condensed ...

ChargePoint (NYSE: CHPT) has disappointed a lot of investors since its public debut. The electric vehicle (EV) charging ...